Solventum Corporation logo SOLV - Solventum Corporation

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 7
HOLD 3
SELL 1
STRONG
SELL 0
| PRICE TARGET: $92.43 DETAILS
HIGH: $100.00
LOW: $78.00
MEDIAN: $93.00
CONSENSUS: $92.43
UPSIDE: 20.30%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 80% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Undervalued Strong
Trading 45.6% below fair value
Current Price $76.83
Bear Case $113.08 47.2% upside ($113.08 - $76.83) / $76.83 = 47.2% $10.24 × 12x P/E
Fair Value $141.36 84.0% upside ($141.36 - $76.83) / $76.83 = 84.0% $10.24 × 15x P/E
Bull Case $169.63 120.8% upside ($169.63 - $76.83) / $76.83 = 120.8% $10.24 × 18x P/E

Adjust Assumptions

15.0x
10.24$

Key Value Driver

Normalized P/E multiple (15x base case)

Implied Market Multiple 7.5x

Plain-Language Summary

Our base-case estimate uses a valuation based on adjusted earnings per share and a normalized price-to-earnings multiple. We then blend that result with the average analyst price target of $92.43 from 11 analysts, using a 20% weight on analyst consensus. That produces an estimated intrinsic value of $141.36 per share.

Warnings

ℹ Wall Street's average price target is $92.43 (from 11 analysts). Our estimate is 66% above the consensus -- consider that gap carefully.

Key Risks

  • Growth DCF inappropriate — terminal value assumptions dominate
  • EV/EBITDA misleading for regulated businesses where capex is mandated
  • Regulatory risk is a fat tail not visible in normal multiples